• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Positive momentum for French biotech industry continues: Abivax announces positive Phase II...

cafead

Administrator
Staff member
  • cafead   Jul 09, 2018 at 11:42: AM
via The positive momentum of French biotech companies continues: Paris-based biotech Abivax this week has announced the top line data from a phase IIa trial assessing ABX464-005, a HIV therapy.

article source